Primenenie poristo-pronitsaemykh inkubatorov iz nikelida titana v kachestve nositeley kletochnykh kul'tur

References

[1] Kirkpatrick C.J., Bittinger F., Wagner M. et al. Current trends in biocompatibility testing. Proc. Inst. Mech. Eng. 1998; 212: 75-84.

[2] Pizzoferrato A., Ciapetti G., Stea S. et al. Cell culture methods for testing biocompatibility. Clin. Mater. 1994; 15: 173-90.

[3] Ramakrishna S., Mayer J., Wintermantel E. et al. Biomedical applications of polymer-composite materials: a review. Compos. Sci.Technol. 2001; 61: 1189-224.

[4] Seal B.L., Otero T.C., Panitch A. Polymeric biomaterials for tissue and organ regeneration. Mater. Sci. Eng. Rep. 2001; 34: 147-230.

[5] Qiu Y., Park K. Superporous ipn hydrogels having enhanced mechanical properties. AAPS Pharmsci Tech. 2003; 4: E51.

[6] Qiu Y, Park K. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev. 2001; 53: 321-39.

[7] Sakiyama-Elbert S.E., Hubbell J.A. Functional biomaterials: design of novel biomaterials. Annu Rev Mater Res. 2001: 183-201.

[8] Jones J.R., Ehrenfried L.M., Hench L.L. Optimising bioactive glass scaffolds for bone tissue engineering. Biomaterials. 2006; 27(7): 964-73.

[9] Rezwana K., Chena Q.Z., Blakera J.J. et al. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006; 27: 3413-41.

[10] Ginty P.J., Howard D., Rose F.R. et al. Mammalian cell survival and processing in supercritical CO2. Proc. Natl. Acad. Sci. USA. 2006; 103: 7426-31.

[11] Regen M., Murphy S., Murphy Т. Drug users' lay consultation processes: symptom identification and management. Advances in Medical Sociology 2002; 8: 323-41.

[12] 12.O'Brien F.J., Harley B.A., Yannas I.V. et al. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds. Biomaterials 2004; 25(6): 1077-86.

[13] Phillips J.E., Hutmacher D.W., Guldberg R.E. et al. Mineralization capacity of Runx2/Cbfa1-genetically engineered fibroblasts is scaffold dependent Biomaterials 2006; 27(32): 5535-45.

[14] Понтер B.3., Ходоренко B.H., Ясенчук Ю.Ф. и др. Никелид титана. Медицинский материал нового поколения. Томск: Изд-во МИЦ; 2006.

[15] Griffith L.G., Naughton G. Tissue engineering - current challenges and expanding opportunities. Science 2002; 295: 1009-114.

[16] Langer R., Vacanti J.P. Tissue engineering. Science 1993; 260: 920-26.

[17] Rikli D.A., Regazzoni P., Perren S.M. Is there a need for resorbable implants or bone substitutes? Injury 2002; 33: 2-3.

[18] Rose F.R., Oreffo R.O. Bone tissue engineering: hope vs. hype. Biochem. Biophys. Res. Commun. 2002; 292: 1-7.

[19] Vacanti J.P., Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 1999; 354: 32-39.

[20] Cancedda R., Dozin В., Giannoni P. et al. Tissue engineering and cell therapy of cartilage and bone. Matrix. Biol. 2003; 22: 81-91.

[21] Kuo C.K., Li W.J., Mauck R.L. et al. Cartilage tissue engineering: its potential and uses. Curr Opin Rheumatol. 2006; 18: 64-73.

[22] Sharma В., Elisseeff J.H. Engineering structurally organized cartilage and bone tissues. Ann. Biomed. Eng. 2004; 32: 148-59.

[23] Гюнтер B.Э., редактор. Материалы с памятью формы и новые технологии в медицине. Томск: Изд-во «НПП МИЦ»; 206.

[24] Кокорев О.В. Противоопухолевое действие трансплантатов фетальных клеток на пористом носителе из никелида титана. Автореф. дис. на соиск. учен. ст. к.м.н. - М.; 2000

[25] Гюнтер В.Э., редактор. Биосовместимые материалы и имплантаты с памятью формы. Томск: STT; 2001. - С. 45-53.

[26] Gunther V.E., editor. Shape memory biomaterials and implants. Proceedings of international conference. Tomsk: STT; 2001. - C. 220-2.

[27] Подольцева З.И. Реакция «трансплантат против опухоли» - перспективный метод иммунотерапии злокачественных новообразований. Практическая онкология 2003; 4(3): 175-82.

[28] Барышников А.Ю. Взаимоотношение опухоли и иммунной системы организма. Практическая онкология 2003; 4(3): 127-30.

[29] Rosenberg S.A., Yang J.С., Restifo N.P. Cancer immunotherapy: moving beyond current vaccines. Nat Med. 2004; 10(9): 909-15.

RIGHTS & PERMISSIONS

Eco-Vector